A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
Abstract Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. The five-year survival rate of HNSCC has not improved even with major technological advancements in surgery and chemotherapy. Currently, docetaxel, cisplatin, and 5-fluoruracil (TPF) treatment has been...
Guardado en:
Autores principales: | Qi Zhong, Jugao Fang, Zhigang Huang, Yifan Yang, Meng Lian, Honggang Liu, Yixiang Zhang, Junhui Ye, Xinjie Hui, Yejun Wang, Ying Ying, Qing Zhang, Yingduan Cheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2b033c9903704388926ac8e5d4b2b0db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oropharynx microbiota transitions in hypopharyngeal carcinoma treatment of induced chemotherapy followed by surgery
por: Hui-Ching Lau, et al.
Publicado: (2021) -
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zhen Zeng, et al.
Publicado: (2018) -
Prognostic value of α2δ1 in hypopharyngeal carcinoma: A retrospective study
por: Liu Qiang, et al.
Publicado: (2021) -
New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers
por: Qinrong Zhang, et al.
Publicado: (2021) -
Efficacy and safety of taxane-based systemic chemotherapy of advanced gastric cancer: A systematic review and meta-analysis
por: Jinxin Shi, et al.
Publicado: (2017)